Article
Epidermal growth factor receptor (EGFR) mutation testing is useful for primary lung cancer diagnosis and appropriate surgical resection: A case series.
Respiratory investigation - 1 Jan 2022
Kitamura Atsushi, Ishii Kenji, Okafuji Kouhei, Kojima Fumitsugu, Bando Toru
Abstract excerpt
Primary lung cancer was suspected in three patients upon chest computed tomography (CT) and bronchoscopy. Wash cytology revealed that all patients had lesions categorized as class III or lower (Papanicolaou classification), and the wash solution was then subjected to an epidermal growth factor receptor (EGFR) mutation search. As a result, exon 19 deletion was found in two patients, whereas an exon 21 L858R...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
